Ceperognastat Shows Promise in Early Symptomatic Alzheimer’s Disease Treatment
A recent study published in JAMA has tested the efficacy of Ceperognastat, an innovative oral small-molecule inhibitor targeting O-linked N-acetylglucosaminidase ...
A recent study published in JAMA has tested the efficacy of Ceperognastat, an innovative oral small-molecule inhibitor targeting O-linked N-acetylglucosaminidase ...
In a groundbreaking study that illuminates the intersection of ophthalmology and neurology, researchers have proposed a novel approach that employs ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine